BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Omeros Corporation (OMER) Release: Omidria Receives Positive Opinion From European Medicines Agency's Committee For Medicinal Products For Human Use 5/22/2015 6:10:38 AM
Omeros Corporation (OMER) Reports First Quarter 2015 Financial Results 5/11/2015 5:02:25 PM
Omeros Corporation (OMER) To Announce First Quarter 2015 Financial Results On May 11, 2015 5/5/2015 6:50:52 AM
Omeros Corporation (OMER) To Present At The 14th Annual Needham Healthcare Conference 4/10/2015 11:08:11 AM
Omeros Corporation (OMER) Announces The U.S. Commercial Launch Of Omidria 4/2/2015 6:39:03 AM
Omeros Corporation (OMER) Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015 10:03:14 AM
Omeros Corporation (OMER) To Announce Fourth Quarter And Full-Year 2014 Financial Results On March 16, 2015 3/10/2015 9:19:12 AM
Omeros Corporation (OMER)'s Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use 2/19/2015 7:41:59 AM
Omeros Corporation (OMER) Closes $84 Million Public Offering of Common Stock And Pre-Funded Warrants 2/4/2015 7:29:46 AM
Omeros Corporation (OMER) Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants 1/29/2015 7:30:11 AM
12345678910...